Sorrento Therapeutics, Inc.
SRNE
Revenue
13.03M
▲7.26M▲125.58%
3 Months ChangeAssets
456.69M
▼-3.37M▼-0.7327%
3 Months ChangeLiabilities
654.65M
▲67.17M▲11.43%
3 Months ChangeFree Cash Flow
-49.55M
▲36.41M▲42.36%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-11-07
Form 8-K
ID: 0001104659-23-115270
2023-11-03
Form 8-K
ID: 0001104659-23-114354
2023-10-27
Form 8-K
ID: 0001104659-23-112178
2023-10-05
Form 8-K
ID: 0001104659-23-107275
2023-09-26
Form 8-K
ID: 0001104659-23-103911
2023-09-13
Form 8-K
ID: 0001104659-23-100179
2023-08-28
Form 8-K
ID: 0001104659-23-096071
2023-08-21
Form 8-K
ID: 0001104659-23-093768
2023-08-14
Form 10-Q
ID: 0000950170-23-041995
2023-08-10
Form 8-K
ID: 0001104659-23-089802